{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:24:47Z","timestamp":1789500287215,"version":"build-2803163510"},"reference-count":99,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1097\/med.0b013e32834b4401","type":"journal-article","created":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T16:12:44Z","timestamp":1377879164000},"page":"339-346","source":"Crossref","is-referenced-by-count":101,"title":["Mechanisms and treatment of hypercalcemia of malignancy"],"prefix":"10.1097","volume":"18","author":[{"given":"Gregory A.","family":"Clines","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20211004","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1023\/A:1026597816193","article-title":"Hypercalcemia of malignancy.","volume":"1","author":"Grill","year":"2000","journal-title":"Rev Endocr Metab Disord"},{"key":"R2-2-20211004","doi-asserted-by":"crossref","first-page":"499","DOI":"10.7326\/0003-4819-112-7-499","article-title":"Cancer-associated hypercalcemia: morbidity and mortality. Clinical experience in 126 treated patients.","volume":"112","author":"Ralston","year":"1990","journal-title":"Ann Inter Med"},{"key":"R3-2-20211004","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.lungcan.2003.09.006","article-title":"Hypercalcemia-leukocytosis syndrome associated with lung cancer.","volume":"43","author":"Hiraki","year":"2004","journal-title":"Lung Cancer"},{"key":"R4-2-20211004","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/0026-0495(82)90012-9","article-title":"The hypercalcemia of malignancy: pathogenesis and management.","volume":"31","author":"Mundy","year":"1982","journal-title":"Metabolism"},{"key":"R6-2-20211004","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1445-2197.1998.tb04719.x","article-title":"Pancreatitis and primary hyperparathyroidism: forty cases.","volume":"68","author":"Carnaille","year":"1998","journal-title":"Aust N Z J Surg"},{"key":"R7-2-20211004","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/clc.4960110205","article-title":"QT intervals as an index of high serum calcium in hypercalcemia.","volume":"11","author":"Saikawa","year":"1988","journal-title":"Clin Cardiol"},{"key":"R8-2-20211004","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/00004714-200004000-00022","article-title":"Hypercalcemia, arrhythmia, and mood stabilizers.","volume":"20","author":"Wolf","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"R9-2-20211004","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.semnephrol.2006.03.004","article-title":"Acquired nephrogenic diabetes insipidus.","volume":"26","author":"Khanna","year":"2006","journal-title":"Semin Nephrol"},{"key":"R10-2-20211004","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1681\/ASN.V9122181","article-title":"Decreased aquaporin-2 expression and apical plasma membrane delivery in kidney collecting ducts of polyuric hypercalcemic rats.","volume":"9","author":"Earm","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"R11-2-20211004","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.1073\/pnas.84.14.5048","article-title":"Parathyroid hormone-related protein purified from a human lung cancer cell line.","volume":"84","author":"Moseley","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R12-2-20211004","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1172\/JCI113275","article-title":"Parathyroid hormone-like protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone.","volume":"80","author":"Strewler","year":"1987","journal-title":"J Clin Invest"},{"key":"R13-2-20211004","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1126\/science.3616618","article-title":"A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression.","volume":"237","author":"Suva","year":"1987","journal-title":"Science"},{"key":"R14-2-20211004","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/bcr1306","article-title":"Key stages of mammary gland development: molecular mechanisms involved in the formation of the embryonic mammary gland.","volume":"7","author":"Hens","year":"2005","journal-title":"Breast Cancer Res"},{"key":"R15-2-20211004","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI200319504","article-title":"Mammary-specific deletion of parathyroid hormone-related protein preserves bone mass during lactation.","volume":"112","author":"VanHouten","year":"2003","journal-title":"J Clin Invest"},{"key":"R16-2-20211004","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1242\/dev.129.12.2977","article-title":"PTHrP and Indian hedgehog control differentiation of growth plate chondrocytes at multiple steps.","volume":"129","author":"Kobayashi","year":"2002","journal-title":"Development"},{"key":"R17-2-20211004","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.2337\/db09-1796","article-title":"Parathyroid hormone-related protein enhances human ss-cell proliferation and function with associated induction of cyclin-dependent kinase 2 and cyclin E expression.","volume":"59","author":"Guthalu Kondegowda","year":"2010","journal-title":"Diabetes"},{"key":"R18-2-20211004","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1359\/jbmr.2001.16.12.2173","article-title":"Midregion parathyroid hormone-related protein inhibits growth and invasion in vitro and tumorigenesis in vivo of human breast cancer cells.","volume":"16","author":"Luparello","year":"2001","journal-title":"J Bone Miner Res"},{"key":"R19-2-20211004","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1100\/tsw.2010.97","article-title":"Midregion PTHrP and human breast cancer cells.","volume":"10","author":"Luparello","year":"2010","journal-title":"ScientificWorldJournal"},{"key":"R20-2-20211004","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1210\/endo-129-6-3424","article-title":"A potent inhibitor of osteoclastic bone resorption within a highly conserved pentapeptide region of parathyroid hormone-related protein: PTHrP107-111.","volume":"129","author":"Fenton","year":"1991","journal-title":"Endocrinology"},{"key":"R21-2-20211004","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/jcb.240540203","article-title":"Tartrate resistant acid phosphatase activity in rat cultured osteoclasts is inhibited by a carboxyl terminal peptide (osteostatin) from parathyroid hormone-related protein.","volume":"54","author":"Zheng","year":"1994","journal-title":"J Cell Biochem"},{"key":"R22-2-20211004","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1073\/pnas.89.7.2732","article-title":"Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium.","volume":"89","author":"Abou-Samra","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R23-2-20211004","doi-asserted-by":"crossref","first-page":"28382","DOI":"10.1074\/jbc.M109.022905","article-title":"Structural basis for parathyroid hormone-related protein binding to the parathyroid hormone receptor and design of conformation-selective peptides.","volume":"284","author":"Pioszak","year":"2009","journal-title":"J Biol Chem"},{"key":"R24-2-20211004","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1210\/endo.140.10.7037","article-title":"Breast cancer cells interact with osteoblasts to support osteoclast formation.","volume":"140","author":"Thomas","year":"1999","journal-title":"Endocrinology"},{"key":"R25-2-20211004","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1172\/JCI115947","article-title":"On the mechanism of parathyroid hormone stimulation of calcium uptake by mouse distal convoluted tubule cells.","volume":"90","author":"Gesek","year":"1992","journal-title":"J Clin Invest"},{"key":"R26-2-20211004","doi-asserted-by":"crossref","first-page":"20125","DOI":"10.1074\/jbc.272.32.20125","article-title":"Parathyroid hormone-dependent degradation of type II NaPi cotransporters.","volume":"272","author":"Pfister","year":"1997","journal-title":"J Biol Chem"},{"key":"R28-2-20211004","first-page":"801","article-title":"Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancy.","volume":"76","author":"Schilling","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"R29-2-20211004","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1210\/me.2007-0274","article-title":"Altered selectivity of parathyroid hormone (PTH) and PTH-related protein (PTHrP) for distinct conformations of the PTHPTHrP receptor.","volume":"22","author":"Dean","year":"2008","journal-title":"Mol Endocrinol"},{"key":"R30-2-20211004","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1359\/JBMR.050602","article-title":"Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D.","volume":"20","author":"Horwitz","year":"2005","journal-title":"J Bone Miner Res"},{"key":"R31-2-20211004","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJM199004193221603","article-title":"Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer.","volume":"322","author":"Burtis","year":"1990","journal-title":"N Engl J Med"},{"key":"R32-2-20211004","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJMcp042806","article-title":"Hypercalcemia associated with cancer.","volume":"352","author":"Stewart","year":"2005","journal-title":"N Engl J Med"},{"issue":"Pt 6","key":"R33-2-20211004","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1177\/000456329002700605","article-title":"Breast cancer-associated hypercalcaemia: a reassessment of renal calcium and phosphate handling.","volume":"27","author":"Gallacher","year":"1990","journal-title":"Ann Clin Biochem"},{"key":"R34-2-20211004","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1210\/jcem-73-6-1309","article-title":"Parathyroid hormone-related protein: elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer.","volume":"73","author":"Grill","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"R35-2-20211004","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/clinchem\/39.3.414","article-title":"Clinical and laboratory studies of a new immunoradiometric assay of parathyroid hormone-related protein.","volume":"39","author":"Fraser","year":"1993","journal-title":"Clin Chem"},{"key":"R36-2-20211004","first-page":"1268","article-title":"Parathyroid hormone-related protein and life expectancy in hypercalcemic cancer patients.","volume":"78","author":"Pecherstorfer","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"R37-2-20211004","first-page":"354","article-title":"Parathyroid hormone-related protein, bone metastases and hypercalcaemia of malignancy.","volume":"78","author":"Bundred","year":"1996","journal-title":"Ann R Coll Surg Engl"},{"key":"R38-2-20211004","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1210\/jcem.84.10.6026","article-title":"Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy.","volume":"84","author":"Rizzoli","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R39-2-20211004","first-page":"1322","article-title":"Development of a sensitive two-site immunoradiometric assay for parathyroid hormone-related peptide: evidence for elevated levels in plasma from patients with adult T-cell leukemialymphoma and B-cell lymphoma.","volume":"79","author":"Ikeda","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"R40-2-20211004","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0002-9343(97)89515-0","article-title":"Parathyroid-hormone-related peptide in hematologic malignancies.","volume":"100","author":"Kremer","year":"1996","journal-title":"Am J Med"},{"key":"R41-2-20211004","first-page":"1023","article-title":"Hypercalcemia induced by parathyroid hormone-related peptide after treatment of squamous cell carcinoma of oral cavity.","volume":"51","author":"Ansari","year":"2003","journal-title":"J Assoc Physicians India"},{"key":"R42-2-20211004","first-page":"258","article-title":"Hypercalcemia induced by parathyroid hormone-related peptide after treatment of carcinoma.","volume":"95","author":"Gover","year":"2002","journal-title":"South Med J"},{"key":"R43-2-20211004","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000086953","article-title":"Parathyroid hormone-related protein and serum calcium in patients with renal cell carcinoma.","volume":"26","author":"Papworth","year":"2005","journal-title":"Tumour Biol"},{"key":"R44-2-20211004","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1007\/s11606-007-0189-1","article-title":"Renal cell carcinoma presenting with paraneoplastic hypercalcemic coma: a case report and review of the literature.","volume":"22","author":"Pepper","year":"2007","journal-title":"J Gen Intern Med"},{"key":"R45-2-20211004","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2169\/internalmedicine.33.673","article-title":"Hypercalcemia caused by PTH-rP associated with lung metastasis from urinary bladder carcinoma: an autopsied case.","volume":"33","author":"Yoshida","year":"1994","journal-title":"Intern Med"},{"key":"R46-2-20211004","first-page":"37","article-title":"Hypercalcemia due to ectopic secretion of parathyroid related protein from pancreatic carcinoma: a case report.","volume":"73","author":"Cavestro","year":"2002","journal-title":"Acta Biomed"},{"key":"R47-2-20211004","doi-asserted-by":"crossref","first-page":"166","DOI":"10.4158\/EP.1.3.166","article-title":"Humoral hypercalcemia of hepatocellular carcinoma associated with elevated levels of parathyroid-hormone-related-peptide.","volume":"1","author":"Pun","year":"1995","journal-title":"Endocr Pract"},{"key":"R48-2-20211004","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1365-2265.1997.1090921.x","article-title":"Intractable hypercalcaemia due to parathyroid hormone-related peptide secretion by a carcinoid tumour.","volume":"46","author":"Mantzoros","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R49-2-20211004","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000017960","article-title":"Hypercalcemia in a patient with malignant melanoma arising in congenital giant pigmented nevus. A case of increased serum level of parathyroid hormone-related protein.","volume":"197","author":"Matsui","year":"1998","journal-title":"Dermatology"},{"key":"R50-2-20211004","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1210\/jcem-68-5-976","article-title":"Ectopic production of parathyroid hormone by small cell lung cancer in a patient with hypercalcemia.","volume":"68","author":"Yoshimoto","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"R51-2-20211004","first-page":"3793","article-title":"Ectopic production of intact parathyroid hormone by a squamous cell lung carcinoma in vivo and in vitro.","volume":"81","author":"Nielsen","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"R52-2-20211004","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJM199011083231907","article-title":"Hypercalcemia and ectopic secretion of parathyroid hormone by an ovarian carcinoma with rearrangement of the gene for parathyroid hormone.","volume":"323","author":"Nussbaum","year":"1990","journal-title":"N Engl J Med"},{"key":"R53-2-20211004","first-page":"1373","article-title":"Production of parathyroid hormone by a malignant nonparathyroid tumor in a hypercalcemic patient.","volume":"76","author":"Strewler","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"R54-2-20211004","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1210\/jcem.83.8.5025","article-title":"Hypercalcemia caused by ectopic production of parathyroid hormone in a patient with papillary adenocarcinoma of the thyroid gland.","volume":"83","author":"Iguchi","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"R55-2-20211004","first-page":"912","article-title":"A thymoma as a cause of true ectopic hyperparathyroidism.","volume":"79","author":"Rizzoli","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"R56-2-20211004","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1385\/ENDO:27:1:083","article-title":"Parathyroid hormone expression in a patient with metastatic nasopharyngeal rhabdomyosarcoma and hypercalcemia.","volume":"27","author":"Wong","year":"2005","journal-title":"Endocrine"},{"key":"R57-2-20211004","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1210\/jc.2005-2095","article-title":"Hypercalcemia of malignancy due to ectopic transactivation of the parathyroid hormone gene.","volume":"91","author":"VanHouten","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R58-2-20211004","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1172\/JCI112614","article-title":"Production of 1,25-dihydroxyvitamin D3 by human T cell lymphotrophic virus-I-transformed lymphocytes.","volume":"78","author":"Fetchick","year":"1986","journal-title":"J Clin Invest"},{"key":"R59-2-20211004","first-page":"888","article-title":"Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase.","volume":"86","author":"Zehnder","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R60-2-20211004","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1359\/jbmr.2003.18.3.579","article-title":"Vitamin D-mediated hypercalcemia in lymphoma: evidence for hormone production by tumor-adjacent macrophages.","volume":"18","author":"Hewison","year":"2003","journal-title":"J Bone Miner Res"},{"key":"R61-2-20211004","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1182\/blood.V82.5.1383.1383","article-title":"Calcitriol: the major humoral mediator of hypercalcemia in Hodgkins disease and non-Hodgkins lymphomas.","volume":"82","author":"Seymour","year":"1993","journal-title":"Blood"},{"key":"R62-2-20211004","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/archsurg.1980.01380060012004","article-title":"Incidence of hypercalcemia and malignant neoplasm.","volume":"115","author":"Burt","year":"1980","journal-title":"Arch Surg"},{"key":"R63-2-20211004","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/jcp.39.10.1143","article-title":"Hypercalcaemia in T cell acute lymphoblastic leukaemia: report of two cases.","volume":"39","author":"Laffan","year":"1986","journal-title":"J Clin Pathol"},{"key":"R64-2-20211004","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0002-9440(10)63343-3","article-title":"Increased expression of 25-hydroxyvitamin D-1alpha-hydroxylase in dysgerminomas: a novel form of humoral hypercalcemia of malignancy.","volume":"165","author":"Evans","year":"2004","journal-title":"Am J Pathol"},{"key":"R65-2-20211004","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1017\/S1462399408000616","article-title":"Molecular mechanisms and treatment of bone metastasis.","volume":"10","author":"Clines","year":"2008","journal-title":"Expert Rev Mol Med"},{"key":"R66-2-20211004","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(00)49915-0","article-title":"The distribution of secondary growths in cancer of the breast.","volume":"133","author":"Paget","year":"1889","journal-title":"Lancet"},{"key":"R67-2-20211004","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G","article-title":"Skeletal complications of malignancy.","volume":"80","author":"Coleman","year":"1997","journal-title":"Cancer"},{"key":"R68-2-20211004","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00008390-200110000-00006","article-title":"Hypercalcaemia of melanoma: incidence, pathogenesis and therapy with bisphosphonates.","volume":"11","author":"des Grottes","year":"2001","journal-title":"Melanoma Res"},{"key":"R69-2-20211004","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/pbc.20063","article-title":"CD19 negative precursor B acute lymphoblastic leukemia presenting with hypercalcemia.","volume":"43","author":"Sultan","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"R70-2-20211004","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/pbc.20357","article-title":"Acute lymphocytic leukemia in adolescence with multiple osteolytic lesions and hypercalcemia mediated by lymphoblast-producing parathyroid hormone-related peptide: a case report and review of the literature.","volume":"45","author":"Shimonodan","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"R71-2-20211004","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1515\/JPEM.2009.22.5.463","article-title":"Childhood aleukemic leukemia with hypercalcemia and bone lesions mimicking metabolic bone disease.","volume":"22","author":"Ganesan","year":"2009","journal-title":"J Pediatr Endocrinol Metab"},{"key":"R72-2-20211004","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/ajh.20559","article-title":"Non-Hodgkins lymphoma presenting as multiple bone lesions and hypercalcemia.","volume":"81","author":"Takasaki","year":"2006","journal-title":"Am J Hematol"},{"key":"R73-2-20211004","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/10428190310001593139","article-title":"Diffuse large B-cell lymphoma presenting with hypercalcemia and multiple osteolysis.","volume":"45","author":"Matsuhashi","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"R74-2-20211004","first-page":"S128","article-title":"PTHrP expression by breast cancer cells enhance osteolytic bone metastases in vivo.","volume":"9","author":"Guise","year":"1994","journal-title":"J Bone Miner Res"},{"key":"R75-2-20211004","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1172\/JCI118947","article-title":"Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis.","volume":"98","author":"Guise","year":"1996","journal-title":"J Clin Invest"},{"key":"R76-2-20211004","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1158\/1541-7786.MCR-09-0131","article-title":"Reconstitution of amphiregulin-epidermal growth factor receptor signaling in lung squamous cell carcinomas activates PTHrP gene expression and contributes to cancer-mediated diseases of the bone.","volume":"7","author":"Gilmore","year":"2009","journal-title":"Mol Cancer Res"},{"key":"R77-2-20211004","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ijc.11586","article-title":"Parathyroid hormone-related protein (PTHrP) is responsible for production of bone metastasis, but not visceral metastasis, by human small cell lung cancer SBC-5 cells in natural killer cell-depleted SCID mice.","volume":"108","author":"Miki","year":"2004","journal-title":"Int J Cancer"},{"key":"R78-2-20211004","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S0959-8049(05)80127-3","article-title":"Parathyroid hormone related protein and skeletal morbidity in breast cancer.","volume":"28","author":"Bundred","year":"1992","journal-title":"Eur J Cancer"},{"key":"R79-2-20211004","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1182\/blood.V96.2.671","article-title":"Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma.","volume":"96","author":"Choi","year":"2000","journal-title":"Blood"},{"key":"R80-2-20211004","doi-asserted-by":"crossref","first-page":"11581","DOI":"10.1073\/pnas.201394498","article-title":"Multiple myeloma disrupts the TRANCEosteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression.","volume":"98","author":"Pearse","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R81-2-20211004","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1182\/blood-2003-06-1992","article-title":"IL-3 expression by myeloma cells increases both osteoclast formation and growth of myeloma cells.","volume":"103","author":"Lee","year":"2004","journal-title":"Blood"},{"key":"R82-2-20211004","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/sj.leu.2402481","article-title":"Distinct IL-6 signal transduction leads to growth arrest and death in B cells or growth promotion and cell survival in myeloma cells.","volume":"16","author":"Cheung","year":"2002","journal-title":"Leukemia"},{"key":"R83-2-20211004","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/jso.2930370104","article-title":"Malignancy and concomitant primary hyperparathyroidism.","volume":"37","author":"Strodel","year":"1988","journal-title":"J Surg Oncol"},{"key":"R84-2-20211004","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/pgmj.71.831.28","article-title":"Survival in hypercalcaemic patients with cancer and co-existing primary hyperparathyroidism.","volume":"71","author":"Hutchesson","year":"1995","journal-title":"Postgrad Med J"},{"key":"R85-2-20211004","first-page":"473","article-title":"Rehydration in the treatment of severe hypercalcaemia.","volume":"50","author":"Hosking","year":"1981","journal-title":"Q J Med"},{"key":"R86-2-20211004","doi-asserted-by":"crossref","first-page":"259","DOI":"10.7326\/0003-4819-149-4-200808190-00007","article-title":"Furosemide for hypercalcemia: an unproven yet common practice narrative review.","volume":"149","author":"LeGrand","year":"2008","journal-title":"Ann Intern Med"},{"key":"R87-2-20211004","doi-asserted-by":"crossref","first-page":"269","DOI":"10.7326\/0003-4819-93-2-269","article-title":"Effect of calcitonin and glucocorticoids in combination on the hypercalcemia of malignancy.","volume":"93","author":"Binstock","year":"1980","journal-title":"Ann Inter Med"},{"key":"R88-2-20211004","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/BF00296210","article-title":"Nasal human calcitonin for tumor-induced hypercalcemia.","volume":"51","author":"Dumon","year":"1992","journal-title":"Calcif Tissue Int"},{"key":"R89-2-20211004","first-page":"2637","article-title":"Synthetic salmon calcitonin as an antihypercalcemic agent for hypercalcemia in malignancy.","volume":"13","author":"Adachi","year":"1986","journal-title":"Gan To Kagaku Ryoho"},{"key":"R90-2-20211004","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.2174\/138161210793563617","article-title":"Molecular targets of the nitrogen containing bisphosphonates: the molecular pharmacology of prenyl synthase inhibition.","volume":"16","author":"Dunford","year":"2010","journal-title":"Curr Pharm Des"},{"key":"R91-2-20211004","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1200\/JCO.1992.10.1.134","article-title":"Comparative study of pamidronate disodium and etidronate disodium in the treatment of cancer-related hypercalcemia.","volume":"10","author":"Gucalp","year":"1992","journal-title":"J Clin Oncol"},{"key":"R92-2-20211004","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0002-9343(93)90282-T","article-title":"Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages.","volume":"95","author":"Nussbaum","year":"1993","journal-title":"Am J Med"},{"key":"R93-2-20211004","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/bjc.1995.502","article-title":"A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy.","volume":"72","author":"Purohit","year":"1995","journal-title":"Br J Cancer"},{"key":"R94-2-20211004","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1001\/archinte.1990.00390210095021","article-title":"Fast and effective treatment of malignant hypercalcemia. Combination of suppositories of calcitonin and a single infusion of 3-amino 1-hydroxypropylidene-1-bisphosphonate.","volume":"150","author":"Thiebaud","year":"1990","journal-title":"Arch Inter Med"},{"key":"R95-2-20211004","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1200\/JCO.2001.19.2.558","article-title":"Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials.","volume":"19","author":"Major","year":"2001","journal-title":"J Clin Oncol"},{"key":"R96-2-20211004","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00520-003-0477-1","article-title":"Efficacy and safety of ibandronate in the treatment of hypercalcemia of malignancy: a randomized multicentric comparison to pamidronate.","volume":"11","author":"Pecherstorfer","year":"2003","journal-title":"Support Care Cancer"},{"key":"R98-2-20211004","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/0002-9343(78)90847-1","article-title":"Pathogenesis of hypercalcemia in lymphosarcoma cell leukemia. Role of an osteoclast activating factor-like substance and a mechanism of action for glucocorticoid therapy.","volume":"65","author":"Mundy","year":"1978","journal-title":"Am J Med"},{"key":"R99-2-20211004","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1159\/000188907","article-title":"Calcium-free hemodialysis for the management of hypercalcemia.","volume":"72","author":"Koo","year":"1996","journal-title":"Nephron"},{"key":"R100-2-20211004","doi-asserted-by":"crossref","first-page":"1174e1","DOI":"10.1016\/j.ajem.2009.01.026","article-title":"Hypercalcemic crisis successfully treated with prompt calcium-free hemodialysis.","volume":"27","author":"Wang","year":"2009","journal-title":"Am J Emerg Med"},{"key":"R101-2-20211004","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis.","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"key":"R102-2-20211004","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1200\/JCO.2010.29.7101","article-title":"Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study.","volume":"28","author":"Stopeck","year":"2010","journal-title":"J Clin Oncol"}],"container-title":["Current Opinion in Endocrinology, Diabetes &amp; Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01266029-201112000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T01:57:17Z","timestamp":1633312637000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01266029-201112000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":99,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/med.0b013e32834b4401","relation":{},"ISSN":["1752-296X"],"issn-type":[{"value":"1752-296X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}